Custos Family Office LLC Has $878,000 Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Custos Family Office LLC raised its position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 132.2% in the first quarter, according to its most recent filing with the SEC. The firm owned 121,306 shares of the company's stock after purchasing an additional 69,060 shares during the quarter. Custos Family Office LLC's holdings in Core Scientific were worth $878,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. KLP Kapitalforvaltning AS bought a new position in shares of Core Scientific during the 4th quarter worth approximately $527,000. Deutsche Bank AG boosted its holdings in shares of Core Scientific by 53.8% during the 4th quarter. Deutsche Bank AG now owns 165,032 shares of the company's stock worth $2,319,000 after buying an additional 57,742 shares in the last quarter. New York State Common Retirement Fund boosted its holdings in shares of Core Scientific by 30.7% during the 4th quarter. New York State Common Retirement Fund now owns 187,181 shares of the company's stock worth $2,630,000 after buying an additional 43,915 shares in the last quarter. Millennium Management LLC bought a new position in shares of Core Scientific in the 4th quarter worth $1,335,000. Finally, LPL Financial LLC lifted its holdings in shares of Core Scientific by 42.9% in the 4th quarter. LPL Financial LLC now owns 421,213 shares of the company's stock worth $5,918,000 after purchasing an additional 126,454 shares in the last quarter.

Core Scientific Stock Performance

Shares of CORZ opened at $16.65 on Monday. The business has a 50-day moving average of $10.67 and a 200 day moving average of $11.03. Core Scientific, Inc. has a fifty-two week low of $6.20 and a fifty-two week high of $18.63. The firm has a market cap of $4.96 billion, a P/E ratio of -3.31 and a beta of 6.33.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.02. The firm had revenue of $79.53 million during the quarter, compared to analysts' expectations of $92.04 million. During the same period last year, the business posted $0.78 EPS. The company's revenue was down 55.6% compared to the same quarter last year. As a group, research analysts predict that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Canaccord Genuity Group reiterated a "buy" rating and issued a $17.00 target price on shares of Core Scientific in a report on Friday. Oppenheimer assumed coverage on Core Scientific in a report on Wednesday, May 14th. They issued an "outperform" rating and a $15.00 target price on the stock. Citigroup assumed coverage on Core Scientific in a report on Thursday, May 22nd. They issued an "outperform" rating on the stock. Roth Mkm reiterated a "buy" rating and issued a $20.00 target price on shares of Core Scientific in a report on Thursday. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $18.00 target price on shares of Core Scientific in a report on Friday. Eighteen equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $18.14.

Insider Buying and Selling

In other news, Director Yadin Rozov acquired 110,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was bought at an average price of $10.87 per share, with a total value of $1,195,700.00. Following the acquisition, the director now owns 475,687 shares in the company, valued at $5,170,717.69. The trade was a 30.08% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Todd M. Duchene sold 7,759 shares of Core Scientific stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $12.39, for a total value of $96,134.01. Following the completion of the sale, the insider now directly owns 2,049,689 shares of the company's stock, valued at approximately $25,395,646.71. This trade represents a 0.38% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 117,759 shares of company stock valued at $1,391,434. 1.40% of the stock is owned by insiders.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.